News

An open letter from our CEO, Joerg Ahlgrimm, to SK pharmteco Customers

An open letter from our CEO, Joerg Ahlgrimm to SK pharmteco Customers SK pharmteco’s mission is to improve patient outcomes and save lives by partnering with our customers to produce and deliver life changing therapies through manufacturing and technical excellence, a positive and adaptable workforce, and an intense focus on safety, quality, and innovation. Our …

An open letter from our CEO, Joerg Ahlgrimm, to SK pharmteco Customers Read More »

SK pharmteco Appoints David Lowndes as Chief Operating Officer

RANCHO CORDOVA, CA – January 9, 2023 – SK pharmteco, a global contract development and manufacturing organization serving the pharmaceutical industry, today announced that David Lowndes will be appointed as Chief Operating Officer. David will lead the company’s global Supply Chain, Quality, Regulatory Affairs, R&D, IT/Digital, and Operational Excellence functions through a period of significant …

SK pharmteco Appoints David Lowndes as Chief Operating Officer Read More »

We’re in the News…Chemical Knowledge Hub features our innovative Skids for Continuous Flow Processing

We’re in the news… check out the latest issue of #chemicalsknowledgehub featuring an article focused on our innovative skids for small scale #continuousflowprocessing developed by teams at our #RanchoCordova site, led by Dr William DuBay VP R&D #SKpharmteco, and AMPAC Fine Chemicals’ Dr John Jacobsen Executive Director R&D and Dr Ryan Woods Senior Manager R&D …

We’re in the News…Chemical Knowledge Hub features our innovative Skids for Continuous Flow Processing Read More »

SK pharmteco announces new standalone Analytical Services from its SK biotek Ireland Swords Campus

SK pharmteco (SKPT) a global CDMO, part of SK Inc., is pleased to announce that it has launched SK biotek Ireland Analytical Services offering full cGMP testing services including testing of Highly Potent Active Pharmaceutical Ingredients (i.e. material with Occupational Exposure Levels (OEL) < 0.1 µg/m³) from SK biotek Ireland’s Dublin-based pharmaceutical manufacturing plant. The …

SK pharmteco announces new standalone Analytical Services from its SK biotek Ireland Swords Campus Read More »

SK pharmteco appoints Joerg Ahlgrimm as CEO

SK pharmteco appoints Joerg Ahlgrimm as CEO November 1, 2022 – SK pharmteco, a global contract development and manufacturing organization (CDMO) serving the pharmaceutical industry, today announced that Joerg Ahlgrimm will be appointed as the Chief Executive Officer. Ahlgrimm will assume the global leadership of the company and spearhead its next phase of innovation and …

SK pharmteco appoints Joerg Ahlgrimm as CEO Read More »

Scroll to Top

Enter your details to access Marketing Materials